Variable | MCT (n = 24) | HIIT (n = 22) | p value |
---|---|---|---|
Hypertension | |||
Yes | 4.2% (n = 1) | 27.3% (n = 6) | p = .043* |
No | 95.8% (n = 23) | 72.7% (n = 16) | |
Afib | |||
Yes | 41.7% (n = 10) | 50.0% (n = 11) | p = .768 |
No | 58.3% (n = 14) | 50.0% (n = 11) | |
Oral anticoagulation | |||
Yes | 29.2% (n = 7) | 45.5% (n = 10) | p = .361 |
No | 70.8% (n = 17) | 54.5% (n = 12) | |
Statin use | |||
Yes | 70.8% (n = 17) | 81.8% (n = 18) | p = .497 |
No | 29.2% (n = 7) | 18.2% (n = 4) | |
Diabetes | |||
Yes | 50.0% (n = 12) | 81.8% (n = 18) | p = .032* |
No | 50.0% (n = 12) | 18.2% (n = 4) | |
BMI > 30 kg/m2 | |||
Yes | 41.7% (n = 10) | 63.6% (n = 14) | p = .155 |
No | 58.3% (n = 14) | 36.4% (n = 8) | |
Nicotine | |||
Yes | 12.5% (n = 3) | 22.7% (n = 5) | p = .451 |
No | 87.5% (n = 21) | 77.3% (n = 17) | |
Stroke | |||
Yes | 62.5% (n = 15) | 86.4% (n = 19) | p = .096 |
No | 37.5% (n = 9) | 13.6% (n = 3) | |
Chronic heart failure | |||
Yes | 25.0% (n = 6) | 63.6% (n = 14) | p = .016* |
No | 75.0% (n = 18) | 36.4% (n = 8) | |
Coronary artery disease | |||
Yes | 79.2% (n = 19) | 81.8% (n = 18) | p = 0.990 |
No | 20.8% (n = 5) | 18.2% (n = 4) | |
COPD | |||
Yes | 54.2% (n = 13) | 54.5% (n = 12) | p = .990 |
No | 45.8% (n = 11) | 45.5% (n = 10) | |
LTOT | |||
Yes | 41.7% (n = 10) | 59.1% (n = 13) | p = .376 |
No | 58.3% (n = 14) | 40.9% (n = 9) | |
NIV | |||
Yes | 54.2% (n = 13) | 54.5% (n = 12) | p = .990 |
No | 45.8% (n = 11) | 45.5% (n = 10) | |
LVEF | |||
> 50% | 62.5% (n = 15) | 90.8% (n = 20) | p = .261 |
40–50% | 25.0% (n = 6) | 4.6% (n = 1) | |
< 40% | 12.5% (n = 3) | 4.6% (n = 1) | |
Valvular dysfunction | |||
Yes | 75.0% (n = 18) | 81.8% (n = 18) | p = .725 |
No | 25.0% (n = 6) | 18.2% (n = 4) |